PEPperPRINT

Executive Summary

PEPperPRINT is a leading German biotechnology company specializing in high-density peptide microarrays for antibody validation, epitope mapping, and antigen discovery. Founded in 2005 and headquartered in Heidelberg, the company offers custom PEPperCHIP® microarrays and PEPperMAP® analytical services, serving academic and pharmaceutical clients in immunology and vaccine development. With a strong focus on precision and reproducibility, PEPperPRINT has established itself as a key enabler in antibody characterization and T-cell fingerprinting. Despite being privately held with limited public financial data, the company's niche technology and long track record position it well within the growing proteomics and diagnostics markets. The company's ability to secure partnerships and expand into clinical applications will be critical for future growth. Given its established reputation and the rising demand for antibody validation tools, PEPperPRINT presents a moderate-to-strong investment opportunity with a conviction score of 68.

Upcoming Catalysts (preview)

• Q4 2026Strategic partnership with a major pharmaceutical company for vaccine development65% success
• Q2 2026Launch of next-generation ultra-high-density peptide microarray platform70% success
• Q1 2027Series B or growth equity funding round to scale commercial operations55% success